Skip to content

Real-world Study on Standardized Treatment of Erectile Dysfunction in China

Real-world Study on Standardized Treatment of Erectile Dysfunction in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113675
Enrollment
Unknown
Registered
2025-12-01
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile dysfunction

Interventions

Observation Group of Erectile dysfunction:None

Sponsors

The Seventh Affiliated Hospital Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Male subjects, aged 18 to 70 years old (inclusive of both lower and upper limits); 2.Those who meet the diagnostic criteria of ED; 3.The subjects voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.The clinically significant anatomical or structural abnormalities of the penis identified by the researchers (including but not limited to): such as a small penis, congenital curvature of the penis, Peyronie's disease, etc. 2.Suffering from diseases that can cause abnormal penile erection (including but not limited to): such as sickle cell anemia, multiple myeloma, leukemia, etc. 3.Having liver damage, a history of stroke or myocardial infarction within the past 6 months, severe hypotension (blood pressure lower than 90/50 mmHg), non-arteritic anterior ischemic optic neuropathy (NAION), and other serious diseases that affect the survival of the subjects. 4.Currently, you are taking any form of nitrate drugs or NO donors: such as nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, etc. 5.Those who are known to be allergic to cilostazol, or who have a history of allergic reactions to 5-type phosphodiesterase (PDE5) inhibitors; 6.The researchers believe that the participants are not suitable for this clinical study.

Design outcomes

Primary

MeasureTime frame
IIEF-5;

Secondary

MeasureTime frame
Prostate fluid routine examination, Prostatic Secretory Granule Excreted Protein (PSEP);Calculate the percentage of responses that indicate "yes" to the GAQ-1 questionnaire.;Blood pressure, fasting blood glucose, glycated hemoglobin;;Total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein.;IPSS score and NIH-CPSI score;Semen examination;Blood pressure, fasting blood sugar, total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein;

Countries

China

Contacts

Public ContactXuan Xujun

The Seventh Affiliated Hospital Sun Yat-sen University

xxjun777@163.com+86 755 8120 6353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026